GGrantIndex
← Leaderboards

Andrew Franklin Teich

Columbia University Health Sciences

$8,004,696
Attributed
$10,109,015
Total exposure
7
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2M · FY201425
$2.5M$1.9M$1.3M$625K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,109,015 · 7

By mechanism

R01$7,061,361 · 2
P30$1,924,874 · 2
K76$632,580 · 1
K08$253,800 · 1
R03$236,400 · 1

Top collaborators

Most similar at Columbia University Health Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposS DiseaseGenesAutopsyPathologyBrain TissueDementiaTissuesBrainGene ExpressionTranscriptome SequencingCognitivePrincipal InvestigatorProgramsTau ProteinsAffectCellsLinkCell TypeWestern WorldGenetic TranscriptionMortalityInvestigationMorbidity - Disease Rate

Grant awards (27)

An investigation of Alzheimer's Disease pathology, microglial immune response, and CSF proteomics in normal pressure hydrocephalus patients$793,799
R01 · FY2025 · AG · contact PI
Neuropath Core$345,988
P30 · FY2025 · AG · contact PI
An investigation of Alzheimer's Disease pathology, microglial immune response, and CSF proteomics in normal pressure hydrocephalus patients$809,998
R01 · FY2024 · AG · contact PI
Neuropathology Core$312,508
P30 · FY2024 · AG · contact PI
An investigation of Alzheimer's Disease pathology, microglial immune response, and CSF proteomics in normal pressure hydrocephalus patients$76,070
R01 · FY2024 · AG · contact PI
An investigation of Alzheimer's Disease pathology, microglial immune response, and CSF proteomics in normal pressure hydrocephalus patients$809,998
R01 · FY2023 · AG · contact PI
Neuropathology Core$315,510
P30 · FY2023 · AG · contact PI
An investigation of Alzheimer's Disease pathology, microglial immune response, and CSF proteomics in normal pressure hydrocephalus patients$84,653
R01 · FY2023 · AG · contact PI
An investigation of Alzheimer's Disease pathology, microglial immune response, and CSF proteomics in normal pressure hydrocephalus patients$14,125
R01 · FY2023 · AG · contact PI
An investigation of Alzheimer's Disease pathology, microglial immune response, and CSF proteomics in normal pressure hydrocephalus patients$809,998
R01 · FY2022 · AG · contact PI
A Translational Bioinformatics Approach to Rescuing Synaptic and Neurophysiologic Dysfunction in Alzheimer's Disease$394,268
R01 · FY2022 · AG · contact PI
Neuropathology Core$318,424
P30 · FY2022 · AG · contact PI
An investigation of Alzheimer's Disease pathology, microglial immune response, and CSF proteomics in normal pressure hydrocephalus patients$809,998
R01 · FY2021 · AG · contact PI
A Translational Bioinformatics Approach to Rescuing Synaptic and Neurophysiologic Dysfunction in Alzheimer's Disease$506,404
R01 · FY2021 · AG · contact PI
A Translational Bioinformatics Approach to Rescuing Synaptic and Neurophysiologic Dysfunction in Alzheimer's Disease$404,508
R01 · FY2021 · AG · contact PI
Neuropathology Core$308,444
P30 · FY2021 · AG · contact PI
A Translational Bioinformatics Approach to Rescuing Synaptic and Neurophysiologic Dysfunction in Alzheimer's Disease$548,188
R01 · FY2020 · AG · contact PI
Neuropathology Core$324,000
P30 · FY2020 · AG · contact PI
A Translational Bioinformatics Approach to Rescuing Synaptic and Neurophysiologic Dysfunction in Alzheimer's Disease$538,623
R01 · FY2019 · AG · contact PI
A Translational Bioinformatics Approach to Rescuing Synaptic and Neurophysiologic Dysfunction in Alzheimer's Disease$460,731
R01 · FY2018 · AG · contact PI
An integrative analysis of DNA methylation, transcriptomic changes, and cognitive dysfunction in Alzheimer's disease$205,668
K76 · FY2018 · AG · contact PI
An integrative analysis of DNA methylation, transcriptomic changes, and cognitive dysfunction in Alzheimer's disease$210,911
K76 · FY2017 · AG · contact PI
An integrative analysis of DNA methylation, transcriptomic changes, and cognitive dysfunction in Alzheimer's disease$216,001
K76 · FY2016 · AG · contact PI
A systems approach to DNA methylation, gene expression, and cognitive dysfunction in Alzheimer's disease$126,900
K08 · FY2016 · AG · contact PI
A systems approach to DNA methylation, gene expression, and cognitive dysfunction in Alzheimer's disease$126,900
K08 · FY2015 · AG · contact PI
A study of ZCCHC17 regulation of synaptic genes in Alzheimers disease$116,400
R03 · FY2015 · AG · contact PI
A study of ZCCHC17 regulation of synaptic genes in Alzheimers disease$120,000
R03 · FY2014 · AG · contact PI